112 related articles for article (PubMed ID: 6734353)
1. Comparative flow DNA analysis of different cell suspensions in breast carcinoma.
Chassevent A; Daver A; Bertrand G; Coic H; Geslin J; Bidabe MC; George P; Larra F
Cytometry; 1984 May; 5(3):263-7. PubMed ID: 6734353
[TBL] [Abstract][Full Text] [Related]
2. Variations in DNA aneuploid cell content during tumor dissociation in human colon and head and neck cancers analyzed by flow cytometry.
Ensley JF; Maciorowski Z; Hassan M; Pietraszkiewicz H; Sakr W; Heilbrun LK
Cytometry; 1993; 14(5):550-8. PubMed ID: 8354128
[TBL] [Abstract][Full Text] [Related]
3. Comparison of five cell cycle analysis models applied to 1414 flow cytometric DNA histograms of fresh frozen breast cancer.
Bergers E; van Diest PJ; Baak JP
Cytometry; 1997 Feb; 30(1):54-60. PubMed ID: 9056743
[TBL] [Abstract][Full Text] [Related]
4. DNA index as prognostic factor in breast cancer.
Rzymowska J; Skierski J; Kurylcio L; Dyrda Z
Neoplasma; 1995; 42(5):239-42. PubMed ID: 8552202
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
6. DNA flow cytometry on breast carcinomas: comparison of a detergent and an enzyme-detergent preparation method.
Risberg B; Stål O; Eriksson LL; Hussein A
Anal Cell Pathol; 1990 Sep; 2(5):287-95. PubMed ID: 2275875
[TBL] [Abstract][Full Text] [Related]
7. DNA in situ sensitivity to denaturation as a marker of human breast tumors.
Kunicka JE; Olszewski W; Rosen PP; Kimmel M; Melamed MR; Darzynkiewicz Z
Cancer Res; 1989 Nov; 49(22):6347-51. PubMed ID: 2804980
[TBL] [Abstract][Full Text] [Related]
8. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
Chen TL; Luo I; Mikhail N; Rasková J; Raska K
Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the malignancy of breast carcinoma using flow cytometry].
Ueki H; Abe R; Kimura M; Kasai M
Gan No Rinsho; 1985 Jul; 31(8):929-32. PubMed ID: 2993696
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence-based analysis of DNA ploidy and cell proliferation within fine-needle samplings of breast tumors: a new approach using automated image cytometry.
Truong K; Vielh P; Malfoy B; Klijanienko J; Dutrillaux B; Bourgeois CA
Cancer; 1998 Oct; 84(5):309-16. PubMed ID: 9801206
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumors.
Ferrero M; Spyratos F; Le Doussal V; Desplaces A; Rouëssé J
Cytometry; 1990; 11(6):716-24. PubMed ID: 1696538
[TBL] [Abstract][Full Text] [Related]
12. [Assay of DNA content and estrogen receptor status in human breast cancer].
Chen GJ; Shao YF; Shan Y
Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):461-4. PubMed ID: 7720507
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.
Stål O; Sullivan S; Sun XF; Wingren S; Nordenskjöld B
Cytometry; 1994 Jun; 16(2):160-8. PubMed ID: 7924685
[TBL] [Abstract][Full Text] [Related]
14. One-tube triple staining method for flow cytometric analysis of DNA ploidy and phenotypic heterogeneity of human solid tumors using single laser excitation.
Corver WE; Bonsing BA; Abeln EC; Vlak-Theil PM; Cornelisse CJ; Fleuren GJ
Cytometry; 1996 Dec; 25(4):358-66. PubMed ID: 8946143
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry analysis of malignant tumors of the head and neck--differences between two methods in the recognition of aneuploidy.
Wennerberg J; Baldetorp B; Wahlberg P; Zätterström UK
Anal Cell Pathol; 1996 Dec; 12(3):125-36. PubMed ID: 9025989
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors.
Van den Berg E; Van Oven MW; de Jong B; Dam A; Wiersema J; Dijkhuizen T; Hoekstra HJ; Molenaar WM
Lab Invest; 1994 Mar; 70(3):307-13. PubMed ID: 8145525
[TBL] [Abstract][Full Text] [Related]
17. A method for dissociation of viable human breast cancer cells that produces flow cytometric kinetic information similar to that obtained by thymidine labeling.
McDivitt RW; Stone KR; Meyer JS
Cancer Res; 1984 Jun; 44(6):2628-33. PubMed ID: 6327021
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
[TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
20. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Budnick RM; Stewart CC
Cancer; 1996 May; 77(9):1844-9. PubMed ID: 8646683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
